TargImmune Therapeutics AG
Latest commercial register entry
Map & Directions
Review
Commercial register ID for TargImmune Therapeutics AG:
CH-270.3.015.322-3
Unique enterprise identification number (UID) for TargImmune Therapeutics AG:
CHE-349.430.797
About TargImmune Therapeutics AG
TargImmune Therapeutics AG, based in Basel, is a company in Switzerland. TargImmune Therapeutics AG is active according to the commercial register. TargImmune Therapeutics AG was registered in the Swiss Commercial Register on February 9, 2016. Itsunique enterprise identification number (UID) is CHE-349.430.797. In the database of the IGE (Swiss Federal Institute for Intellectual Property) there are currently several trademarks or applications for the company TargImmune Therapeutics AG.
A total of 29 official publications concerning TargImmune Therapeutics AG have been recorded on HELP.CH in the Swiss Official Gazette of Commerce (SOGC) database, which contains publications from January 2007 onwards. You can see the latest publication by company TargImmune Therapeutics AG from August 27, 2026 on this link.
Registered Business Purpose of TargImmune Therapeutics AG
The purpose of the company is to research, develop, manufacture, exploit, purchase and sell pharmaceutical and diagnostic products and technologies. The company can acquire, hold and sell all types of intellectual property rights and licenses. The company may enter into all commercial, contractual and financial transactions that are suitable to further the purpose of the company or that are directly or indirectly related to it. It can also set up branches at home and abroad and participate in other companies or merge with them.
Automatically translated from German.TargImmune Therapeutics AG in Basel is listed on Yellowpages.swiss. Latitude and longitude coordinates for TargImmune Therapeutics AG are: 47.5523153 and 7.6038935. The Swiss enterprise identification number (UID) of TargImmune Therapeutics AG is CHE-349.430.797.
Primary Data Source: Swiss Commercial Register (SOGC / FSO)
Last update on June 12, 2026
Other companies registered at the same address as TargImmune Therapeutics AG (St. Alban-Anlage 70, 4052 Basel) include: NanoPhoria Switzerland AG | Tenpoint Therapeutics GmbH | Doris Fink Recruiting & Consulting GmbH .
Press Releases from TargImmune Therapeutics AG
Useful Information about TargImmune Therapeutics AG in Basel
An overview of key information and frequently asked questions about TargImmune Therapeutics AG in Basel.
Where is TargImmune Therapeutics AG located?
The registered address of TargImmune Therapeutics AG is: St. Alban-Anlage 70, 4052 Basel
When was TargImmune Therapeutics AG established?
TargImmune Therapeutics AG was officially entered into the Swiss Commercial Register on February 9, 2016. The actual year of establishment may differ.
About Basel
TargImmune Therapeutics AG is registered in the municipality of Basel. Basel is a municipality in the canton of Basle Town. Basle Town is a canton in the German-speaking part of Switzerland. The capital and also the most populous place is Basle. The canton belongs to the economic region of Northwestern Switzerland and the cross-border metropolitan region of Basle. The canton of Basle Town is one of 26 cantons in the Swiss Confederation.
Basel is a municipality in the canton of Basle Town, in the country of Switzerland, on the continent of Europe. Latitude and longitude coordinates for Basel are: 47.5595986 and 7.5885761. The local date and time in Basel is October 25, 2026, 5:31 PM.
The information on this entry in the commercial register of the legal entity TargImmune Therapeutics AG is provided without guarantee and has no legal effect. Only the certified extracts from the commercial register and the publication texts in the Swiss Official Gazette of Commerce (SOGC) are binding.
Search Directory
Gurit reports solid third-quarter performance and reiterates full-year guidance Gurit Services AG, 2026-10-23
Sika delivers strong nine-month results with 4.8% sales growth in local currencies and reiterates 2026 guidance Sika AG, 2026-10-23
Romande Energie accelerates progress towards its target of 5 TWh of low-carbon power generation Romande Energie SA, 2026-10-22
